NYBCe operates Blood Bank of Delmarva, Community Blood Center of Kansas City, Connecticut Blood Center, Memorial Blood Centers, Nebraska Community Blood Bank, New Jersey Blood Services, New York Blood Center, and Rhode Island Blood Center, delivering one million blood products to 400+ U.S. hospitals annually. This is an opportunity for a senior life sciences investor to take on significant deal ownership and portfolio leadership within one of the world's leading blood and biotherapeutics organizations, with direct exposure to a differentiated portfolio spanning hematology, cell therapy, biologics, and adjacent fields.